Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Ethosuximide Capsules, 250 mg, Banner Pharmacaps ANDA 40-430 10/28/02 Ethosuximide Syrup,250 mg/5 mL, Pharmaceutical Associates, ANDA 40-253 Zarontin (ethosuximide) Capsules, Pfizer NDA 12-380/S29 4/19/02 5/2/02 Zarontin (ethosuximide) 250 mg Capsules and 250 mg/5 ml Syrup. Parket-Davis NDA 12380/S-22/23/25 ETHOSUXIMIDE Capsule; 250MG ETHOSUXIMIDE BANNER PHARMACAPS 012380 ETHOSUXIMIDE Capsule; 250MG ZARONTIN PARKE DAVIS 081306 ETHOSUXIMIDE Syrup; 250MG/5ML ETHOSUXIMIDE Copley 080258 ETHOSUXIMIDE Syrup; 250MG/5ML ZARONTIN PARKE DAVIS 040253 ETHOSUXIMIDE Syrup; 250MG/5ML ETHOSUXIMIDE ASSOC | Zarontin Capsules, Pfizer, Labeling Supplement | Ethosuximide Capsules, Covenant Pharma, Inc., Approval ^ FDA's latest approval appears at the bottom of this list. ^   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2008 Betterchem.com